| Quarter | Score |
|---|---|
| 2022-Q3 | 40.8 |
| 2022-Q4 | 49.8 |
| 2023-Q2 | 41.6 |
| 2023-Q3 | 48.7 |
| 2023-Q4 | 65.6 |
| 2024-Q1 | 50.6 |
| 2024-Q2 | 49.0 |
| 2024-Q3 | 86.4 |
| 2024-Q4 | 86.2 |
| 2025-Q1 | 86.2 |
| 2025-Q2 | 70.6 |
| 2025-Q3 | 70.3 |
| 2025-Q4 | 84.1 |
| 2026-Q1 | 82.9 |
| 2026-Q2 | 83.0 |
Funds reducing exposure or consensus momentum fading
Trading +189.6% above funds' purchase price — elevated pullback risk
2 of 18 tracked funds hold GTX. Avg conviction: 1.9%. Net trimming. First tracked at $9.06 (current +189.6% vs tracked).
Oaktree Capital has 3.8% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 3.8% | Reduce |
| Citadel Advisors | 0.0% | Reduce |